skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography

Journal Article · · Proc. Natl. Acad. Sci. U.S.A.; (United States)

Two substituted benzamides, FLB 524 and raclopride, were labeled with C and examined for their possible use as ligands for positron emission tomography (PET) scan studies on dopamine-2 (D-2) receptors in the brains of monkeys and healthy human subjects. Both ligands allowed the in vivo visualization of D-2 receptor binding in the corpus striatum caudate nucleus/putamen complex in PET-scan images. ( C)Raclopride showed a high ratio of specific striatal to nonspecific cerebellar binding, and the kinetics of binding of this ligand made it optimal for PET studies. The in vivo binding of ( C)raclopride in the striatum of cynomolgus monkeys was markedly reduced by displacement with haloperidol. In healthy human subjects, ( C)raclopride binding in the caudate nucleus/putamen was 4- to 5-fold greater than nonspecific binding in the cerebellum. In comparison with previously available ligands for PET-scan studies on central dopamine receptors in man, ( C)raclopride appears to be advantageous with regard to (i) specificity of binding to D-2 receptors, (ii) the high ratio between binding in dopamine-rich (caudate, putamen) and dopamine-poor (cerebellum) human brain regions, and (iii) rapid association and reversibility of specific binding.

Research Organization:
Karolinska Institute, Stockholm, Sweden
OSTI ID:
6289618
Journal Information:
Proc. Natl. Acad. Sci. U.S.A.; (United States), Vol. 82:11
Country of Publication:
United States
Language:
English

Similar Records

3-(2'-( sup 18 F)fluoroethyl)spiperone: In vivo biochemical and kinetic characterization in rodents, nonhuman primates, and humans
Journal Article · Fri Dec 01 00:00:00 EST 1989 · Journal of Cerebral Blood Flow and Metabolism; (USA) · OSTI ID:6289618

The characterization of IBF as a new selective dopamine D-2 receptor imaging agent
Journal Article · Tue May 01 00:00:00 EDT 1990 · Journal of Nuclear Medicine; (USA) · OSTI ID:6289618

In vitro binding properties and autoradiographic imaging of 3-iodobenzamide ((/sup 125/I)-IBZM): a potential imaging ligand for D-2 dopamine receptors in SPECT
Journal Article · Fri Jan 01 00:00:00 EST 1988 · Life Sci.; (United States) · OSTI ID:6289618